DANIEL RIVERA: Open Payments
NPI 1104530914 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$913 in 7 payments from 5 companies in 2025. Trend: 2023 $616 · 2024 $1,341 · 2025 $913
Food & beverage: $913
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $348 |
| Janssen Pharmaceuticals, Inc | 1 | $241 |
| Neurocrine BioSciences, Inc. | 1 | $119 |
| Otsuka America Pharmaceutical, Inc. | 1 | $118 |
| Axsome Therapeutics, Inc. | 1 | $87 |
Products named: AUSTEDO XR, INVEGA SUSTENNA, INGREZZA, REXULTI, Auvelity.
Industry payments across OH — which companies pay providers there.
